The drug, REL-1017, did not show statistically significant improvement in symptoms of depression when compared to a placebo
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2gzDSbW
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Relmada's depression drug fails to meet late-stage study goal
https://ift.tt/I6BJijA
No comments:
Post a Comment